Introduction to Pharmacology and Phase 1 Clinical Trials

Hosted at: The Institute of Clinical Research Training Suite

Starts On: June 22, 2021

Finishes: June 22, 2021

10

CPD Points

The Course

The course will give an overview of clinical pharmacology, define phase 1 studies and describe how they fit into the clinical development programme. Delegates will be guided through the regulatory and clinical aspects of phase 1 studies and identify the key safety and ethical issues that need to be managed. The issues relating to design, set-up, choosing subjects and conduct of phase 1 studies will be discussed. The course will use trainer input, exercises, and delegate interaction.

Learning Objectives

• Give an overview of Clinical Pharmacology. 

• Define Phase 1 studies and describe how they fit into the clinical development programme. 

• The delegates will be guided through the regulatory and clinical aspects of Phase 1 studies and identify the key safety and ethical issues that need to be managed.  

• The issues relating to design, set-up, choosing subjects and conduct of Phase 1 studies will be discussed.


Course Outline

• Clinical Pharmacology – terminology and definitions.

• Overview of Phase 1 Studies 

• Patient populations. 

• Phase 1 clinics. 

• Ethical considerations.

• The EU Directive and legal requirements. 

• Types of Phase I studies 

• Considerations in Phase I study design. 

• Adverse events/adverse drug reactions.  

• Data collection and monitoring.

Course Documentation

To apply for this course, prices are dependent on your membership status:
Acceptance by WorldPay ensures that your place is booked and guaranteed
To pay by invoice please contact ICR on 01628 501700
Guest ICR Member ICR Member (Academic)
Debit card Credit card Debit card Credit card Debit card Credit card
£550.00 £550.00